title: Chyloperitoneum in pediatric peritoneal dialysis: rapid remission after introduction of medium-chain triglyceride-based formula.
authors: J
authors: J
authors: Lanneaux
authors: A
authors: A
authors: Davourie-Salandre
authors: E
authors: E
authors: Tudorache
authors: I
authors: I
authors: Stoica
authors: B
authors: B
authors: Aoun
authors: T
authors: T
authors: Ulinski
mesh_terms: D002915:Chylous Ascites / Q000209:etiology / Q000628:therapy*; D015314:Dialysis Solutions; D004041:Dietary Fats / Q000008:administration & dosage; D004108:Dilatation, Pathologic; D006801:Humans; D007223:Infant; D008297:Male; D008894:Milk Proteins / Q000627:therapeutic use*; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D012074:Remission Induction; D014521:Urethra / Q000473:pathology
chemical_list: D015314:Dialysis Solutions; D004041:Dietary Fats; D008894:Milk Proteins; C482039:Monogen
references: Nephrol Dial Transplant. 1991;6(9):659-61
references: 1745391
references: Nephrology (Carlton). 2005 Aug;10(4):344-7
references: 16109079
references: Pediatr Nephrol. 1995 Dec;9(6):753-5
references: 8747121
references: Perit Dial Int. 2008 May-Jun;28(3):229-31
references: 18474912
references: J Am Coll Surg. 2011 May;212(5):899-905.e1-4
references: 21398159
references: Perit Dial Int. 2000 Nov-Dec;20(6):610-24
references: 11216549